The Pharma
Talent Command
Center.
GxP-critical roles for CRAs, RA specialists, formulation chemists, and the CDMOs racing to fill them before audit season.
Open Roles
1,247
+23 today
URGENT Hires
184
Audit deadline < 30d
Avg Salary (RA)
$127K
+14% vs Q4 2025
Talent Shortage
2.4×
Demand vs supply
Geographic Demand · Active Clusters
The Market Is Moving
Without You.
Three data findings from our Q1 2026 life sciences labor analysis. Each one is a signal. Together, they're a deadline.
+14%
RA Salary Growth · Q1 2026
Median Base ($K) by Role
Senior RA managers now command $142K base — up from $124K in Q4 2025. Candidates know their value. Do your offers reflect that?
67 days
Avg Time-to-Fill · CMC Roles
Avg Days to Fill by Role
CMC roles now take 84 days average to fill. Every day an open QC seat sits empty is a day your audit readiness degrades.
6 metros
Concentrate 78% of demand
Open Roles by Metro (Active)
Boston and NJ/NYC combined hold 599 active pharma roles. Basel just surpassed San Diego in open CMC postings for the first time.
Biotech layoffs in 18 months
Most affected workers left the industry — not into your pipeline.
RA professionals unhappy in role
Down from 69% satisfaction in Sept 2024. The window to poach is open.
US life sciences workers — record high
Yet critical GxP roles remain unfilled. The gap is structural, not cyclical.
The Gap Is Structural.
Your Competitors Already Know.
The CDMO hiring surge is real — and it's not slowing.
CROs and CDMOs are scaling operations for speed and compliance. QC analysts with aseptic processing experience are vanishingly rare. Proclinical is now placing more contract CMC roles than permanent ones globally.
Senior RA talent is retiring. The next generation isn't ready.
A significant experience gap is opening in global eCTD filings, post-approval changes, and digital submission systems. IND specialists with advanced therapy experience are overbooked 6 months out.
$50B in new US manufacturing means 4,000+ new GxP roles by 2027.
Novartis ($23B) and Eli Lilly ($27B) are building US manufacturing capacity now. Process validation engineers, QA leads, and regulatory writers are needed before the first batch is released.
Tech is stealing your candidates. Veeva fluency is table stakes.
Pharma is competing for data scientists, bioinformatics specialists, and digital transformation leads against FAANG offers. Candidates proficient in Veeva, IQVIA, and cloud LIMS are fielding 4+ offers simultaneously.
CONCLUSION · FORMULARY INTELLIGENCE UNIT
The data is conclusive. Your next GxP hire will take longer, cost more, and face more competition than your last one.
Get the Full
Talent Report
34-page Q1 2026 pharmaceutical labor market analysis. Salary benchmarks by role and metro. Time-to-fill projections through Q4. CDMO demand forecast.